Drugs / Islet cell transplantation
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00708604 | Oct 2008 → Jun 2014 | type 1 diabetes mellitus | City of Hope Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT00214786 | Apr 2005 → Jul 2007 | type 1 diabetes mellitus | Baylor Research Institute | Completed | No outcome recorded |
| Phase 1 | NCT00303134 | Aug 2003 → Oct 2007 | type 1 diabetes mellitus | Weill Medical College of Cornell University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Islet cell transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00214786 ↗ |
| Modality | Cell therapy | “pancreatic islet cell transplantation” NCT00214786 ↗ |
| Route | Other | “The islets obtained are injected into the liver in the recipient via percutaneous catheterization of the portal venous system.” NCT00214786 ↗ |